The human equivalent of roughly 0.035 mg represents a tiny fraction of the standard skin rejuvenation dose, suggesting that neurological benefits may occur alongside skin improvements at typical protocol dosages
Common Mild Side Effects Short-term redness or slight irritation at the injection site Light water retention, especially during the initial weeks Increased appetite Mild headaches (rare and usually transient) Temporary fatigue or lightheadedness immediately after injection Who Should Avoid This Therapy People with an active cancer diagnosis or history of cancer, as GH secretagogues increase cellular replication rates Pregnant or breastfeeding individuals should avoid this therapy due to insufficient safety data on its effects during these stages
Water intake becomes even more critical when combined with higher fiber consumption from vegetables, which requires adequate fluid to move through your digestive tract smoothly
A comprehensive overview is available in the tirzepatide supplement guide
Tamoxifen decreases insulin-like growth factor type 1, a factor that stimulates cancer cell growth and development and induces the secretion of transforming growth factor beta (TGF-beta) which is associated with inhibiting the activity of breast cancer cells
More GLP-1s are coming from Eli Lilly, from Roche, from a dozen others queuing up behind them